Monday, April 26, 2021 10:30:43 AM
December 10, 2020
Page 4
A R I Z O N A C A L I F O R N I A F L O R I D A K E N T U C K Y M I C H I G A N
N E V A D A O H I O T E N N E S S E E T E X A S T O R O N T O W A S H I N G T O N D C
4822-1799-4707 v4 [93656-1]
To the best knowledge of counsel, the Issuer has not been a “shell company” as defined
in Rules 405 of the Securities Act of 1933 and 12 b-2 of the Exchange Act of 1934.
No person other than OTC Markets Group Inc. is entitled to rely on this letter, but OTC
Markets Group Inc. is hereby granted full and complete permission and rights to publish this letter
through the OTC Disclosure & News Service for viewing by the public and regulators.
Sincerely,
DICKINSON WRIGHT PLLC
Joel D. Mayersohn, Member
cc: HeadsUp Entertainment, Inc. (via email)
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM